Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous TILs in Advanced Biliary Tract Cancers
NCT03801083Phase 2Active, not recruiting
- Start
- Feb 2019
- Primary completion
- Jan 2030
- Modality
- Monoclonal Antibodies, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous tumor-infiltrating lymphocytes in biliary tract cancer (BTC). Started Feb 2019; status: active, not recruiting.
02
Drugs
autologous tumor-infiltrating lymphocytes
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT03801083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03801083.